Table 5.
Estimated Costs for Continued Surveillance and Supplementary Immunization Activity Monitoring in Afghanistan and Pakistan for Modeled Scenarios for 2019–2023
| A, Campaign Quality Monitoring Costs | ||||||
|---|---|---|---|---|---|---|
| 2019–2020 | No. of SIAs With LQAS Monitoring | No. of Lots | Costs | |||
| Afghanistan | 13 | 1207 | 1 931 200 | |||
| Pakistan | 7 | 4974 | 7 958 400 | |||
| 2021–2023 | Fraction Targeted by LQAS, % | No. of Lots | Costs | |||
| Afghanistan | 0.15 | 2374 | 3 798 400 | |||
| Average | 0.11 | 1741 | 2 785 600 | |||
| Minimum | 0.17 | 2690 | 4 305 000 | |||
| Maximum | ||||||
| Pakistan | 0.15 | 11 701 | 18 721 600 | |||
| Average | 0.05 | 3900 | 6 240 000 | |||
| Minimum | 0.29 | 22 622 | 36 195 200 | |||
| Maximum | ||||||
| 2019–2023 | No. of Lots | Costs | ||||
| Total | 20 256 | 32 409 600 | ||||
| Average | 11 822 | 18 915 200 | ||||
| Minimum | 31 493 | 50 388 800 | ||||
| Maximum | ||||||
| B, AFP Surveillance Costs | ||||||
| Year | Afghanistan | Pakistan | Total Cost | |||
| Adjusted | Unadjusted | Adjusted | Unadjusted | Adjusted | Unadjusted | |
| 2019 | 646 288 | 2 585 152 | 4 554 938 | 16 701 438 | 5 201 225 | 19 286 589 |
| 2020 | 651 234 | 2 604 936 | 4 614 825 | 16 921 025 | 5 266 059 | 19 525 960 |
| 2021 | 656 459 | 2 625 836 | 4 679 238 | 17 157 205 | 5 335 697 | 19 783 041 |
| 2022 | 660 942 | 2 643 766 | 4 735 644 | 17 364 027 | 5 396 585 | 20 007 794 |
| 2023 | 664 871 | 2 659 484 | 4 785 670 | 17 547 457 | 5 450 541 | 20 206 942 |
| Total | 3 279 793 | 13 119 173 | 23 370 314 | 85 691 152 | 26 650 107 | 98 810 325 |
| C, ES Costs | ||||||
| Year | Afghanistan | Pakistan | Total Cost | |||
| No. of Samples | Costs | No. of Samples | Costs | |||
| 2019 | 264 | 264 000 | 860 | 1 720 000 | 1 984 000 | |
| 2020 | 414 | 414 000 | 816 | 1 632 000 | 2 046 000 | |
| 2021 | ||||||
| Baseline | 414 | 414 000 | 816 | 1 632 000 | 2 046 000 | |
| Default | 276 | 276 000 | 1 908 000 | |||
| Reactive | 552 | 552 000 | 2 184 000 | |||
| 2022 | ||||||
| Baseline | 414 | 414 000 | 816 | 1 632 000 | 2 046 000 | |
| Default | 276 | 276 000 | 1 908 000 | |||
| Reactive | 552 | 552 000 | 2 184 000 | |||
| 2023 | ||||||
| Baseline | 414 | 414 000 | 816 | 1 632 000 | 2 046 000 | |
| Default | 276 | 276 000 | 1 908 000 | |||
| Reactive | 552 | 552 000 | 2 184 000 | |||
| Total | ||||||
| Baseline | 1920 | 1 920 000 | 4124 | 8 248 000 | 10 168 000 | |
| Default | 1506 | 1 506 000 | 9 754 000 | |||
| Reactive | 2334 | 2 334 000 | 10 582 000 | |||
Abbreviations: AFP, acute flaccid paralysis; ES, environmental surveillance; LQAS, lot quality assurance survey; SIA, supplementary immunization activity.